GM Botulinum toxin type A – Use in Adults for consultation
The Botulinum toxin type A – Use in Adults document is available for comment on the GMMMG website until 11th November 2016:
Please click here to access and provide your feedback.
The policy is intended for use in patients within the Greater Manchester health economy and we are therefore seeking comments from all Greater Manchester healthcare professionals. The pharmaceutical industry is invited to comment on factual inaccuracies only.